Inhibition of resistance plasmid transfer in Escherichia coli by ionophores, chlortetracycline, bacitracin, and ionophore/antimicrobial combinations

Avian Dis. 2004 Apr-Jun;48(2):317-23. doi: 10.1637/7105.

Abstract

Medicinal feed additives bacitracin, chlortetracycline (CTC), laidlomycin, lasalocid, and salinomycin inhibited the transfer of multiresistance-conferring plasmid pBR325 (Tet(r) Amp(r) Cp(r), 6.0 kb) into selected gram-negative strains with the use of an in vitro model. High concentrations of ampicillin-sensitive competence-pretreated Escherichia coli HB 101 cells were exposed to 10% (v/v) of 1:10 dimethyl sulfoxide/agent : water containing test mixtures for 0.5 hr prior to plasmid addition and transforming conditions. Transformation was inhibited for all antimicrobials and showed a positive association wich higher concentration. Additional testing of ionophore compounds separately and in combination with bacitracin, chlortetracycline, lincomycin, roxarsone, tylosin, and virginiamycin at representative feed concentrations demonstrated 80.6% to >99.9% inhibition (P < 0.001) of resistance transfer. Bacitracin alone inhibited transformation within the range of 50-500 ppm. No increase in resistance transfer was observed when poultry-derived and reference gram-negative isolates having low or no transformation efficiency were additionally tested. The results suggest that these compounds, at relevant concentrations used in animal feed, may interfere with cell envelope-associated DNA uptake channels or other transformation competence mechanisms. Through these mechanisms, ionophores and cell membrane-interactive feed agents such as CTC and bacitracin may act to inhibit resistance transfer mechanisms within poultry and livestock.

MeSH terms

  • Bacitracin / pharmacology*
  • Chlortetracycline / pharmacology*
  • Drug Resistance, Bacterial*
  • Drug Therapy, Combination / pharmacology*
  • Escherichia coli / drug effects*
  • Ionophores / pharmacology*
  • Lasalocid / pharmacokinetics
  • Lasalocid / pharmacology
  • Monensin / analogs & derivatives*
  • Monensin / pharmacokinetics
  • Plasmids
  • Pyrans / pharmacology
  • Roxarsone / pharmacokinetics
  • Transformation, Bacterial / drug effects*
  • Transformation, Bacterial / genetics
  • Tylosin / pharmacology
  • Virginiamycin / pharmacology

Substances

  • Ionophores
  • Pyrans
  • Virginiamycin
  • Bacitracin
  • salinomycin
  • Monensin
  • Roxarsone
  • laidlomycin
  • Lasalocid
  • Chlortetracycline
  • Tylosin